ERBB2 and breast carcinoma: There were also apparent increases in LPP2 mRNA in ER positive (3.0-fold), HER2 positive (6.0-fold), and ER/PR/HER2 positive (3.8-fold) breast cancer compared to normal breast tissue, although these did not reach statistical significance (Figure 1A).